-
Calvert, Hilary Alan
Hilary Calvert, a British oncologist, was responsible for the early clinical development of carboplatin, the analogue of cisplatin that showed similar anti-tumour activity to the parent compound with markedly less toxicity.
Read more -
Cleare, Mike
Michael Cleare, a British chemist, worked for Johnson Matthey, a materials company, from 1966 to 1999 where he was involved in the discovery and development of the second-generation platinum chemotherapy, carboplatin.
Read more -
Connors, Tom
Tom Connors was a British chemist and pharmacologist who graduated in physiology from University College London in 1957, and gained an organic chemistry PhD in alkylating agents from the Chester Beatty Research Institute (subsequently the Institute of Cancer Research (ICR), London), in 1960.
Read more
-
Larsson, Börje
Börje Larsson was a biologist who held academic positions at Uppsala and Zurich universities and who played a key role the field of radiation therapy, radiosurgery and the development of the Gamma Knife machine with Lars Leksell.
Read more -
Leksell, Lars
Lars Leksell was a pioneering neurosurgeon, and the father of stereotactic radiosurgery and the Gamma Knife machine now used to treat brain tumours at many locations globally.
Read more -
Lévi, Francis
Francis Lévi, a French medical oncologist, led the development of oxaliplatin at all phase.
Read more
-
Machover, David
Machover is a French oncologist best known for the discovery in 1982 that the effectiveness of fluoropyrimidines in colorectal and gastric cancers could be enhanced by addition of folate.
Read more -
Mathé, Georges
While French oncologist and immunologist Georges Mathé is best known for performing the first successful allogeneic bone marrow transplant he also played a significant role in developing the third-generation platinum anticancer drug, oxaliplatin.
Read more -
Misset, Jean-Louis
In 1986, French oncologist Jean-Louis Misset led the phase I trial of oxaliplatin at Paul Brousse Hospital, Paris.
Read more